• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Heart attack and stroke patients prescribed statin medication upon…

Bioengineer.org by Bioengineer.org
January 30, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Intermountain Medical Center Heart Institute.

Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they're discharged from the hospital, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City.

Prior surveys in hospitals found that statins, a common medication prescribed to lower cholesterol, aren't being used as consistently in patients who've been admitted to the hospital following a heart attack or stroke. Researchers also found that when the medication is prescribed, dosing is likely not as high as it should be to provide optimal benefits.

Researchers from the Intermountain Medical Center Heart Institute examined more than 62,000 records of patients from the Intermountain Healthcare system between 1999 and 2013 who survived an initial atherosclerotic cardiovascular disease event , such as a heart attack or stroke. They were then followed for three years, or until death, to identify the effectiveness of statin use prescribed at the time of their discharge.

"Patients who were prescribed a statin medication following an initial heart attack or stroke reduced their risk of a future adverse event such as a future heart attack, stroke, revascularization, or death, by almost 25% — the rate dropped from 34 percent to 26 percent," said Jeffrey L. Anderson, MD, cardiovascular researcher at the Intermountain Medical Center Heart Institute. "The patients who were discharged on what's considered a high-intensity dose of a statin saw a 21 percent reduction in their risk than those discharged on a low-intensity statin dose."

Results of the study will be reported at the 2017 American Heart Association Scientific Sessions in Anaheim, CA, on November 13, at 11:30 a.m., PST.

People with high cholesterol face an increased risk of heart attack, stroke, or other forms of heart disease. Statins are medications used to help lower cholesterol levels in the blood, thus reducing a person's risk of cardiovascular injury or death.

Intermountain Medical Center Heart Institute researchers found that 30 percent of patients in the study who were discharged from the hospital following a heart attack or stroke weren't prescribed a statin, which led to worse outcomes for those patients.

Researchers also found that only 13 percent of patients were given a high-intensity dose of statins – but noted that patients on those higher doses experienced fewer heart attacks or strokes. For those under 76 years of age, a high-intensity statin is indicated by American Heart Association guidelines, yet only 17.7 percent of these patients in the study were discharged on a high-intensity dose.

"In a real-world clinical setting, we noted that patients who'd just experienced a major cardiovascular event weren't always prescribed a statin, and others didn't have doses that were high enough to provide optimal outcomes," said Dr. Anderson. "The key takeaway for clinicians and patients is that statins work, and routinely prescribing a statin and the optimal dose for the patient will help improve outcomes by lowering risk of a repeat heart attack, stroke or revascularization procedure such as a stent or bypass surgery."

###

Other members of the research team include Kirk U. Knowlton, MD; Heidi May, PhD; Tami Bair, RN; Donald L. Lappé, MD; and Joseph B. Muhlestein, MD.

The Intermountain Medical Center Heart Institute, part of the Intermountain Healthcare system based in Salt Lake City, is one of the premier cardiovascular centers in the country.

Media Contact

Jess C. Gomez
801-718-8495
@IntermtnMedCtr

http://www.ihc.com

Share12Tweet8Share2ShareShareShare2

Related Posts

Breaking the Blood–Brain Barrier in Pediatric CNS Tumors

Breaking the Blood–Brain Barrier in Pediatric CNS Tumors

August 19, 2025
Prenatal Exposure to Chlorpyrifos Linked to Brain Abnormalities in Children

Prenatal Exposure to Chlorpyrifos Linked to Brain Abnormalities in Children

August 19, 2025

Cadonilimab Shows Promise in Advanced Gynecological Cancers

August 19, 2025

Nerolidol and Cyclophosphamide Combat Breast Cancer Cells

August 19, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    80 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Breaking the Blood–Brain Barrier in Pediatric CNS Tumors

Prenatal Exposure to Chlorpyrifos Linked to Brain Abnormalities in Children

Cadonilimab Shows Promise in Advanced Gynecological Cancers

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.